Sooil Development Co., Ltd. well known for its long history and tradition of insulin pumps, participated in the 78th American Diabetes Association and its exhibitions held June 22-26 at the Orange County Convention Center, in Orlando, Florida. This year's Scientific Sessions together more than 14,000 total attendees, including more than 11,500 physicians, clinicians, nurses, dietitians, CDEs, scientists, and researchers from across the globe. 

Sooil development, which has the largest booth among Korean company, has attracted the attention of participants throughout the exhibition. Sooil development introduced the advantages of the ubiquitous system equipped with Dana insulin pumps to many clinicians and diabetics visiting the exhibition hall.

In particular, the information on new products and next-generation insulin pump models has been released, and medical consultants and overseas buyers have been continuously inquired. Joint research and development proposals have been steadily proving their popularity for Dana insulin pumps all over the world.

Sooil development maintains the existing products continuously, so it is evaluated as a company that puts the convenience of users first.  These services prove the brand value of Dana again to the clinicians all over the world as well as the United States of America.

American Diabetes Association (ADA) is one of the most prestigious international conferences. Over than 20,000 diabetes experts participate annually to share up-to-date insights and publish guidelines for diabetes care worldwide.

Sooil development, which has successfully completed the conference and exhibition, plans to participate in the upcoming European Diabetes Association (EASD) exhibition scheduled for October.